Addiction Disorders Drugs Market Size, Share, Growth, and Industry Analysis, By Types (Alcohol, Marijuana, Prescription & Over-the-Counter Medications, ), By Applications (Counseling & Behavioral Therapies, Detoxification, Medications, ) , and Regional Insights and Forecast to 2035

Table of Content



1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Addiction Disorders Drugs Market Size

1.3 Market Segmentation

1.4 Regulatory Environment



2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Addiction Disorders Drugs Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Addiction Disorders Drugs Business Mode and Production Process

2.3.1 Addiction Disorders Drugs Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Addiction Disorders Drugs Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Addiction Disorders Drugs

2.4.2 Raw Material Cost of Addiction Disorders Drugs

2.4.3 Labor Cost of Addiction Disorders Drugs

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis



3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War



4 Market Competitive Landscape

4.1 Global Addiction Disorders Drugs Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Addiction Disorders Drugs Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Addiction Disorders Drugs Price by Manufacturer (2021-2026)

4.4 Addiction Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Addiction Disorders Drugs, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Addiction Disorders Drugs, Product Offered and Application

4.7 Addiction Disorders Drugs Market Competitive Situation and Trends

4.7.1 Addiction Disorders Drugs Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Addiction Disorders Drugs Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans



5 Global Addiction Disorders Drugs Market Historical Development by Geographic Region (2021-2026)

5.1 Global Addiction Disorders Drugs Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Addiction Disorders Drugs Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Addiction Disorders Drugs Market Status by Country (2021-2026)

5.3.1 North America Addiction Disorders Drugs Sales Volume by Country (2021-2026)

5.3.2 North America Addiction Disorders Drugs Revenue by Country (2021-2026)

5.3.3 United States Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Addiction Disorders Drugs Market Status by Country (2021-2026)

5.4.1 Europe Addiction Disorders Drugs Sales Volume by Country (2021-2026)

5.4.2 Europe Addiction Disorders Drugs Revenue by Country (2021-2026)

5.4.3 Germany Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Addiction Disorders Drugs Market Status by Country (2021-2026)

5.5.1 Asia Pacific Addiction Disorders Drugs Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Addiction Disorders Drugs Revenue by Country (2021-2026)

5.5.3 China Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Addiction Disorders Drugs Market Status by Country (2021-2026)

5.6.1 Latin America Addiction Disorders Drugs Sales Volume by Country (2021-2026)

5.6.2 Latin America Addiction Disorders Drugs Revenue by Country (2021-2026)

5.6.3 Mexico Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Addiction Disorders Drugs Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Addiction Disorders Drugs Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Addiction Disorders Drugs Revenue by Country (2021-2026)

5.7.3 GCC Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Addiction Disorders Drugs Sales Volume, Revenue and Growth (2021-2026)



6 Global Addiction Disorders Drugs Market Historical Development by Product Type (2021-2026)

6.1 Addiction Disorders Drugs Definition by Type

6.2 Global Addiction Disorders Drugs Historical Sales Volume by Product Type (2021-2026)

6.3 Global Addiction Disorders Drugs Historical Revenue by Product Type (2021-2026)

6.4 Global Addiction Disorders Drugs Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Addiction Disorders Drugs Historical Sales Volume, Revenue and Growth Rate of Alcohol (2021-2026)
6.5.2 Global Addiction Disorders Drugs Historical Sales Volume, Revenue and Growth Rate of Marijuana (2021-2026)
6.5.3 Global Addiction Disorders Drugs Historical Sales Volume, Revenue and Growth Rate of Prescription & Over-the-Counter Medications (2021-2026)


7 Global Addiction Disorders Drugs Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Addiction Disorders Drugs Historical Sales Volume by End User (2021-2026)

7.3 Global Addiction Disorders Drugs Historical Revenue by End User (2021-2026)

7.4 Global Addiction Disorders Drugs Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Addiction Disorders Drugs Historical Sales Volume, Revenue and Growth Rate of Counseling & Behavioral Therapies (2021-2026)
7.5.2 Global Addiction Disorders Drugs Historical Sales Volume, Revenue and Growth Rate of Detoxification (2021-2026)
7.5.3 Global Addiction Disorders Drugs Historical Sales Volume, Revenue and Growth Rate of Medications (2021-2026)


8 Leading Companies Profiles

8.1 Cipla Limited
8.1.1 Cipla Limited Corporation Information
8.1.2 Cipla Limited - Addiction Disorders Drugs Product Portfolio and Specification
8.1.3 Cipla Limited Performance Analysis (2021-2026)
8.1.4 Cipla Limited Business and Markets Served
8.1.5 Cipla Limited Recent Developments
8.2 Aurobindo Pharma Limited
8.2.1 Aurobindo Pharma Limited Corporation Information
8.2.2 Aurobindo Pharma Limited - Addiction Disorders Drugs Product Portfolio and Specification
8.2.3 Aurobindo Pharma Limited Performance Analysis (2021-2026)
8.2.4 Aurobindo Pharma Limited Business and Markets Served
8.2.5 Aurobindo Pharma Limited Recent Developments
8.3 Mallinckrodt Pharmaceuticals
8.3.1 Mallinckrodt Pharmaceuticals Corporation Information
8.3.2 Mallinckrodt Pharmaceuticals - Addiction Disorders Drugs Product Portfolio and Specification
8.3.3 Mallinckrodt Pharmaceuticals Performance Analysis (2021-2026)
8.3.4 Mallinckrodt Pharmaceuticals Business and Markets Served
8.3.5 Mallinckrodt Pharmaceuticals Recent Developments
8.4 Purdue Pharma L.P.
8.4.1 Purdue Pharma L.P. Corporation Information
8.4.2 Purdue Pharma L.P. - Addiction Disorders Drugs Product Portfolio and Specification
8.4.3 Purdue Pharma L.P. Performance Analysis (2021-2026)
8.4.4 Purdue Pharma L.P. Business and Markets Served
8.4.5 Purdue Pharma L.P. Recent Developments
8.5 Psychemedics Corporation
8.5.1 Psychemedics Corporation Corporation Information
8.5.2 Psychemedics Corporation - Addiction Disorders Drugs Product Portfolio and Specification
8.5.3 Psychemedics Corporation Performance Analysis (2021-2026)
8.5.4 Psychemedics Corporation Business and Markets Served
8.5.5 Psychemedics Corporation Recent Developments
8.6 Sun Pharmaceutical Industries Limited
8.6.1 Sun Pharmaceutical Industries Limited Corporation Information
8.6.2 Sun Pharmaceutical Industries Limited - Addiction Disorders Drugs Product Portfolio and Specification
8.6.3 Sun Pharmaceutical Industries Limited Performance Analysis (2021-2026)
8.6.4 Sun Pharmaceutical Industries Limited Business and Markets Served
8.6.5 Sun Pharmaceutical Industries Limited Recent Developments
8.7 Pfizer
8.7.1 Pfizer Corporation Information
8.7.2 Pfizer - Addiction Disorders Drugs Product Portfolio and Specification
8.7.3 Pfizer Performance Analysis (2021-2026)
8.7.4 Pfizer Business and Markets Served
8.7.5 Pfizer Recent Developments
8.8 Medtronic PLC
8.8.1 Medtronic PLC Corporation Information
8.8.2 Medtronic PLC - Addiction Disorders Drugs Product Portfolio and Specification
8.8.3 Medtronic PLC Performance Analysis (2021-2026)
8.8.4 Medtronic PLC Business and Markets Served
8.8.5 Medtronic PLC Recent Developments
8.9 Perrigo Company PLC
8.9.1 Perrigo Company PLC Corporation Information
8.9.2 Perrigo Company PLC - Addiction Disorders Drugs Product Portfolio and Specification
8.9.3 Perrigo Company PLC Performance Analysis (2021-2026)
8.9.4 Perrigo Company PLC Business and Markets Served
8.9.5 Perrigo Company PLC Recent Developments
8.10 GlaxoSmithKline PLC
8.10.1 GlaxoSmithKline PLC Corporation Information
8.10.2 GlaxoSmithKline PLC - Addiction Disorders Drugs Product Portfolio and Specification
8.10.3 GlaxoSmithKline PLC Performance Analysis (2021-2026)
8.10.4 GlaxoSmithKline PLC Business and Markets Served
8.10.5 GlaxoSmithKline PLC Recent Developments
8.11 Takeda Pharmaceutical Company Ltd
8.11.1 Takeda Pharmaceutical Company Ltd Corporation Information
8.11.2 Takeda Pharmaceutical Company Ltd - Addiction Disorders Drugs Product Portfolio and Specification
8.11.3 Takeda Pharmaceutical Company Ltd Performance Analysis (2021-2026)
8.11.4 Takeda Pharmaceutical Company Ltd Business and Markets Served
8.11.5 Takeda Pharmaceutical Company Ltd Recent Developments
8.12 BioCorRx Inc.
8.12.1 BioCorRx Inc. Corporation Information
8.12.2 BioCorRx Inc. - Addiction Disorders Drugs Product Portfolio and Specification
8.12.3 BioCorRx Inc. Performance Analysis (2021-2026)
8.12.4 BioCorRx Inc. Business and Markets Served
8.12.5 BioCorRx Inc. Recent Developments
8.13 Alkermes PLC
8.13.1 Alkermes PLC Corporation Information
8.13.2 Alkermes PLC - Addiction Disorders Drugs Product Portfolio and Specification
8.13.3 Alkermes PLC Performance Analysis (2021-2026)
8.13.4 Alkermes PLC Business and Markets Served
8.13.5 Alkermes PLC Recent Developments
8.14 Novartis AG
8.14.1 Novartis AG Corporation Information
8.14.2 Novartis AG - Addiction Disorders Drugs Product Portfolio and Specification
8.14.3 Novartis AG Performance Analysis (2021-2026)
8.14.4 Novartis AG Business and Markets Served
8.14.5 Novartis AG Recent Developments
8.15 Insys Therapeutics
8.15.1 Insys Therapeutics Corporation Information
8.15.2 Insys Therapeutics - Addiction Disorders Drugs Product Portfolio and Specification
8.15.3 Insys Therapeutics Performance Analysis (2021-2026)
8.15.4 Insys Therapeutics Business and Markets Served
8.15.5 Insys Therapeutics Recent Developments
8.16 eva Pharmaceutical Industries
8.16.1 eva Pharmaceutical Industries Corporation Information
8.16.2 eva Pharmaceutical Industries - Addiction Disorders Drugs Product Portfolio and Specification
8.16.3 eva Pharmaceutical Industries Performance Analysis (2021-2026)
8.16.4 eva Pharmaceutical Industries Business and Markets Served
8.16.5 eva Pharmaceutical Industries Recent Developments
8.17 Consern Pharma Limited
8.17.1 Consern Pharma Limited Corporation Information
8.17.2 Consern Pharma Limited - Addiction Disorders Drugs Product Portfolio and Specification
8.17.3 Consern Pharma Limited Performance Analysis (2021-2026)
8.17.4 Consern Pharma Limited Business and Markets Served
8.17.5 Consern Pharma Limited Recent Developments
8.18 Reckitt Benckiser Pharmaceuticals
8.18.1 Reckitt Benckiser Pharmaceuticals Corporation Information
8.18.2 Reckitt Benckiser Pharmaceuticals - Addiction Disorders Drugs Product Portfolio and Specification
8.18.3 Reckitt Benckiser Pharmaceuticals Performance Analysis (2021-2026)
8.18.4 Reckitt Benckiser Pharmaceuticals Business and Markets Served
8.18.5 Reckitt Benckiser Pharmaceuticals Recent Developments
8.19 Accord Healthcare Limited
8.19.1 Accord Healthcare Limited Corporation Information
8.19.2 Accord Healthcare Limited - Addiction Disorders Drugs Product Portfolio and Specification
8.19.3 Accord Healthcare Limited Performance Analysis (2021-2026)
8.19.4 Accord Healthcare Limited Business and Markets Served
8.19.5 Accord Healthcare Limited Recent Developments


9 Global Addiction Disorders Drugs Market Forecast by Product Type and End User (2026-2034)

9.1 Global Addiction Disorders Drugs Market Forecast by Product Type (2026-2034)

9.1.1 Global Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth Rate of Alcohol (2026-2034)
9.1.2 Global Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth Rate of Marijuana (2026-2034)
9.1.3 Global Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth Rate of Prescription & Over-the-Counter Medications (2026-2034)
9.2 Global Addiction Disorders Drugs Market Forecast by End User (2026-2034)

9.2.1 Global Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth Rate of Counseling & Behavioral Therapies (2026-2034)
9.2.2 Global Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth Rate of Detoxification (2026-2034)
9.2.3 Global Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth Rate of Medications (2026-2034)


10 Global Addiction Disorders Drugs Market Forecast by Geographic Region (2026-2034)

10.1 Global Addiction Disorders Drugs Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Addiction Disorders Drugs Sales Volume, Revenue Forecast and Growth (2026-2034)



11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer